Sign in

CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
460574869
Phone
(857) 284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-21 Lucidi Bruno Director Grant or award · Stock Option (Right to Buy) +41,200 41,200
2024-06-21 Polsky Bruce Director Grant or award · Restricted Stock Units +29,600 29,600
2024-06-21 Polsky Bruce Director Grant or award · Stock Option (Right to Buy) +41,200 41,200
2024-06-21 Murphy Polly A. Director Grant or award · Restricted Stock Units +29,600 29,600
2024-06-21 Murphy Polly A. Director Grant or award · Stock Option (Right to Buy) +41,200 41,200
2024-06-20 Polsky Bruce Director Sale −17,544 $3.49 $61K 65,606
2024-06-16 Murphy Polly A. Director Option exercise +33,150 56,445
2024-06-16 Murphy Polly A. Director Option exercise · Restricted Stock Units −33,150 0
2024-06-16 Lucidi Bruno Director Option exercise +33,150 83,150
2024-06-16 Lucidi Bruno Director Option exercise · Restricted Stock Units −33,150 0
2024-06-16 BERGER FRANKLIN M Director Option exercise +33,150 811,503
2024-06-16 BERGER FRANKLIN M Director Option exercise · Restricted Stock Units −33,150 0
2024-06-16 Polsky Bruce Director Option exercise +33,150 83,150
2024-06-16 Polsky Bruce Director Option exercise · Restricted Stock Units −33,150 0
2024-06-16 Duncan Barbara Gayle Director Option exercise +33,150 33,150
2024-06-16 Duncan Barbara Gayle Director Option exercise · Restricted Stock Units −33,150 0
2024-06-16 Adams Jerome M. Director Option exercise +33,150 33,150
2024-06-16 Adams Jerome M. Director Option exercise · Restricted Stock Units −33,150 0
2024-06-05 Sommadossi Jean-Pierre President, CEO, and Chairman Sale 10b5-1 −1,006 $4.00 $4K 5,923,994
2024-02-01 Corcoran Andrea See Remarks Sale −15,843 $3.84 $61K 670,208

Page 8 of 14 · 280 trades